How to design and launch a successful Clinical Trial Manufacturing.

The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a ...

4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform ...

Its maker, Sarepta Therapeutics, hasn’t ruled out the possibility that the treatment, which uses an adeno-associated virus vector to ... alternative to adenovirus vectors, the first type used ...

Liver damage is a known risk with Elevidys and other gene therapies that use adeno-associated viral vectors to infuse modified genes. This was the first death reported in a patient who was treated ...

D Molecular Therapeutics, Inc.’s FDMT share price has dipped by 10.90%, which has investors questioning if this is right time to buy.

Amplicons for amp R are shown in red, pAAV-ZsGreen1 backbone unique in green, E4 in blue, and rep in yellow. rAAV, recombinant adeno-associated virus. Credit: Human Gene Therapy (2025). DOI: 10. ...

Cell and Gene therapy, particularly using adeno-associated virus vectors, is showing promise in addressing inherited retinal diseases such as retinitis pigmentosa and Leber congenital amaurosis by ...